{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:49:06Z","timestamp":1782740946833,"version":"3.54.5"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,5]]},"DOI":"10.7759\/cureus.15465","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T15:05:56Z","timestamp":1622905556000},"source":"Crossref","is-referenced-by-count":11,"title":["Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event"],"prefix":"10.7759","author":[{"given":"Andrew  V","family":"Doodnauth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohannes  S","family":"Mulatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra R","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krunal H","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy I.","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000491631","article-title":"Acute kidney injury after pembrolizumab-induced adrenalitis and adrenal insufficiency","volume":"8","author":"Hanna RM","year":"2018","unstructured":"Hanna RM, Selamet U, Bui P, et al.. Acute kidney injury after pembrolizumab-induced adrenalitis and adrenal insufficiency. Case Rep Nephrol Dial. 2018, 8:171-7. 10.1159\/000491631","journal-title":"Case Rep Nephrol Dial"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/yty038","article-title":"Cardiac tamponade and adrenal insufficiency due to pembrolizumab: a case report","volume":"2","author":"Oristrell G","year":"2018","unstructured":"Oristrell G, Ba\u00f1eras J, Ros J, Mu\u00f1oz E. Cardiac tamponade and adrenal insufficiency due to pembrolizumab: a case report. Eur Heart J Case Rep. 2018, 2:yty038. 10.1093\/ehjcr\/yty038","journal-title":"Eur Heart J Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56026-5","article-title":"Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database","volume":"9","author":"Garon-Czmil J","year":"2019","unstructured":"Garon-Czmil J, Petitpain N, Rouby F, et al.. Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database. Sci Rep. 2019, 9:19419. 10.1038\/s41598-019-56026-5","journal-title":"Sci Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008002","article-title":"Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody","volume":"6","author":"Iwama S","year":"2014","unstructured":"Iwama S, De Remigis A, Callahan MK, Slovin SF, Wolchok JD, Caturegli P. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci Transl Med. 2014, 6:230ra45. 10.1126\/scitranslmed.3008002","journal-title":"Sci Transl Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3008-19","article-title":"Progression of hypopituitarism and hypothyroidism after treatment with pembrolizumab in a patient with adrenal metastasis from non-small-cell lung cancer","volume":"58","author":"Yamagata S","year":"2019","unstructured":"Yamagata S, Kageyama K, Takayasu S, Asari Y, Makita K, Terui K, Daimon M. Progression of hypopituitarism and hypothyroidism after treatment with pembrolizumab in a patient with adrenal metastasis from non-small-cell lung cancer. Intern Med. 2019, 58:3557-62. 10.2169\/internalmedicine.3008-19","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12088","article-title":"Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors","volume":"7","author":"Mei Y","year":"2016","unstructured":"Mei Y, Bi WL, Greenwald NF, et al.. Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors. Oncotarget. 2016, 7:76565-76. 10.18632\/oncotarget.12088","journal-title":"Oncotarget"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0238","article-title":"Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis","volume":"181","author":"Faje A","year":"2019","unstructured":"Faje A, Reynolds K, Zubiri L, et al.. Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis. Eur J Endocrinol. 2019, 181:211-9. 10.1530\/EJE-19-0238","journal-title":"Eur J Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/60694-pembrolizumab-induced-hypophysitis-with-isolated-adrenocorticotropic-hormone-acth-deficiency-a-rare-immune-mediated-adverse-event","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:17Z","timestamp":1707507257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/60694-pembrolizumab-induced-hypophysitis-with-isolated-adrenocorticotropic-hormone-acth-deficiency-a-rare-immune-mediated-adverse-event"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,5]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.15465","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,5]]}}}